Our Mission

LiberaTx seeks to address the unmet medical need of enhancing oral bioavailability of medications for various diseases. Using its proprietary technology, LiberaTx reformulates existing marketed pharmaceuticals to improve treatment outcomes, while reducing pill burden in patients. In addition, LiberaTx is working with partners to formulate novel biopharmaceuticals and nutraceuticals to promote general health and well-being.

Singapore researchers develop pill that delivers medication to Parkinson's patients over 24 hours

From up to six pills a day to just one. Singapore researchers from NTU have developed a new pill designed to deliver medication over 24 hours to patients of Parkinson's disease. This could mean fewer limb spasms, often experienced when the levodopa drug, or L-dopa, wears off. Researchers have started talks with the National Neuroscience Institute and aim to begin clinical trials by end-2021. The microcapsules are made up of L-dopa and when swallowed, stay and float in the stomach, which enables a slow and continuous delivery compared to conventional pills that quickly breakdown and are absorbed in the intestines.

Making Medicines Better For Patients

test-214185_1280.jpg

Our Technology

 

LiberaTx uses its proprietary technology to reformulate existing marketed pharmaceuticals to improve treatment outcomes, while reducing pill burden in patients.

 

ABOUT US

Assoc. Prof. Joachim Loo
Founder
Kaarunya Sampathkumar
Senior Scientist
Sashi Kesavapany
Co-Founder & CEO
medication-pills-isolated-on-yellow-back

CONTACT US

LiberaTx Pte Ltd

190 Bukit Timah Road,  Singapore 229857

 
LiberaTx Pte Ltd
UEN: 202014991H
LOCATION
(Office) 190 Bukit Timah Road, Singapore 229857
(Lab) School of Materials Science and Engineering, 50 Nanyang Avenue, Singapore 639798